OTC COMPANY STRATEGIES 2018
14 March 2018 - Deborah Wilkes
The OTC Company Strategies 2018 REPORT – 'Winning in a changing world' – provides a comprehensive guide to company strategies and developments in the global OTC/consumer healthcare market.
The 270-page Report is essential reading for both those working in the industry and suppliers who need to keep up-to-date with developments at their customers.
These are challenging times for the OTC/consumer healthcare industry. Disruptive forces are changing the business environment, global sales growth is slowing down, and consolidation is reshaping the fragmented industry.
Companies of all shapes and sizes are busy adapting their strategies to win in this changing competitive landscape.
This authoritative publication provides an Executive Summary plus 18 Company Strategy Profiles for the world’s top OTC players plus a selection of other companies that are driving change. Companies profiled in the Report are:
- Bayer Consumer Health
- Church & Dwight
- GlaxoSmithKline Consumer Healthcare
- HRA Pharma
- Johnson & Johnson
- Merck Consumer Health
- Nature's Bounty
- Pfizer Consumer Healthcare
- Prestige Brands
- Procter & Gamble, PGT Healthcare and Teva
- RB, formerly Reckitt Benckiser
- Sanofi Consumer Healthcare
- Stada Arzneimittel
- Taisho Pharmaceutical
The OTCToolbox Company Strategies Report is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.
This Report, which has more than 270 pages, is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Report. The publication is also available free to people with an Annual Subscription to the OTCToolbox website.